1
Same. Some women had symptoms variably (i.e. having one or more measurements without symptoms and then again reporting symptoms). Younger women did not systematically have more bothersome symptoms than older women. Comparing the proportions of women with bothersome symptoms at various times to those in the crosssectional analysis of Table 2 reveals relatively similar percentages. For comparison, w
1
Ps were very similar by the studied background characteristics. Table 2 gives the prevalence of vasomotor symptoms according to a cross-sectional analysis. At the time of recruitment, about two thirds of the women reported vasomotor symptoms, and about a half regarded them as bothersome. In the survey a year later, less (53 ) of women reported vasomotor symptoms and a third found them bothersome.
1
Among all menopausal women (occurring in 16?2 of premenopausal, 39?7 of perimenopausal and 35?0* Correspondence: elina.hemminki@thl.fi 1 National Institute for Health and Welfare (THL), P.O. Box 3000271, Helsinki, Finland Full list of author information is available at the end of the articleof postmenopausal women). In a Finnish populationbased study by Hemminki et al. (1995), 28 of women aged
1
Same. Some women had symptoms variably (i.e. having one or more measurements without symptoms and then again reporting symptoms). Younger women did not systematically have more bothersome symptoms than older women. Comparing the proportions of women with bothersome symptoms at various times to those in the crosssectional analysis of Table 2 reveals relatively similar percentages. For comparison, w
1
Unmilola OM, Taiwo LO: Experience of menopausal symptoms by women in an urban community in Ibadan, Nigeria. Menopause 2008, 16:1?. 5. R str K, Bengtsson C, Lissner L, Milsom I, Sundh V, Bj kelund C: A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause 2002, 9:156?61. 6. National Institutes of Health state of sci
1
Used. With the current knowledge on the mixed effect on diseases, it might be feasible to find a representative cohort of new menopausal women without HT for follow-up studies.8.9.10. 11.Conclusion There was a notable variability in the development of disturbing vasomotor symptoms over time in a selected group of women aged 50 -59. Population-based followup studies of untreated women would be usef
1
E therapy to either placebo or nothing (the control groups) [21]. Women were recruited in Estonia from 1999?001, and followed by annually mailed questionnaires in 2000?004. Detailed descriptions of the recruitment, inclusion and exclusion criteria, trial treatment, adherence, follow-up and trial outcomes as well as the content of information leaflets and trial questionnaires have been published el
1
Men's experience of the menopause. Br J Obstet Gynaecol 1996, 103:1025?028. Mitchell ES, Woods NF: Symptom experiences of midlife women: observations from the Seattle midlife women's health study. Maturitas 1996, 25:1?0. Jokinen K, Rautava P, M inen J, Ojanlatva A, Sundell J, Helenius H: Experience of climacteric symptoms among 42?6 and 52?6-year-old women. Maturitas 2003, 46:199?05. Col NF, Guthr